Psychedelics and Cannabis: Hype, hope, or harm
Join us on September 24 to learn and share the latest research insights on Psychedelics and Cannabis. Speakers will include local and international experts presenting on various topics.
Join us on Tuesday, September 24, 2024 for Psychedelics and Cannabis: Hype, hope or harm!
Join us for an engaging and informative research day where leading experts will present the latest research on psychedelics and cannabis. This event offers a unique opportunity to explore the therapeutic potential, risks, and societal impacts of these substances, informed by cutting-edge science and clinical insights.
Our featured speakers include Dr. Ziva Cooper, Dr. Margaret Haney, Dr. Gillinder Bedi, and Dr. Frederick Barrett, who will share their extensive knowledge and research findings on various aspects of psychedelics and cannabis.
In addition to the expert presentations, there will be trainee presentations showcasing the latest research from emerging scholars in the field. This event is a must-attend for anyone interested in the evolving landscape of psychedelics and cannabis research, whether you're a researcher, clinician, policymaker, or simply curious about the topic.
Please note: Food will be reserved for those who register for the Welcome Back town hall.
Tentative Schedule
Updated Monday, September 16.
| 8:00 - 8:50 | Coffee and Registration |
| 8:50 - 9:00 | Opening Remarks: Dr. Matt Hill, PhD |
| 9:00 - 10:00 | Plenary Speaker: Dr. Ziva Cooper, PhD THC-sparing Effects of Cannabis Consituents: Potential to Reduce Harms and Improve Outcomes? |
| 10:00 - 11:00 | Plenary Speaker: Dr. Gillinder Bedi, PhD MDMA-assisted Psychotherapy: Building Back Better |
| 11:00 - 1:00 | Welcome Back Town Hall (Lunch and poster presentations) |
| 1:00 - 2:00 | Plenary Speaker: Dr. Margaret Haney, PhD Cannabis Use Disorder: Research and Treatment |
| 2:00 - 2:15 | Trainee Speaker: Jessica Scheufen, Hill Lab The Neurodevelopment Effects of Cannabis Exposure During Adolescence |
| 2:15 - 2:30 | Trainee Speaker: Gavin Petrie, Mayo Lab The Impact of Elevated Anandamide on Symptom Severity in Patients with PTSD |
| 2:30 - 3:00 | Coffee Break |
| 3:00 - 3:15 | Trainee Speaker: Sarah Cook, Bains Lab Acute Effects of Psilocybin on the HPA Axis |
| 3:15 - 4:15 | Plenary Speaker: Dr. Frederick Barrett, PhD Psilocybin for the Treatment of Co-occurring Substance Use and Mood Disorders |
| 4:15 - 4:30 | Closing Remarks |